These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 19331217

  • 21. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control.
    Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N, Nakano T.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):995-1001. PubMed ID: 16406396
    [Abstract] [Full Text] [Related]

  • 22. [A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
    Iwasaki K, Oida I, Usami A, Hashimoto Y, Yamada M, Ozawa T.
    Gan To Kagaku Ryoho; 1999 Feb 15; 26(3):369-72. PubMed ID: 10065103
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Neoadjuvant chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy for larynx preservation in patients with advanced laryngeal cancer.
    Andreadis C, Iliopoulou C, Sidiras T, Boutis A, Diamantopoulos N, Vahtsevanos K, Gennatas K, Mouratidou D.
    J BUON; 2007 Feb 15; 12(3):341-7. PubMed ID: 17918287
    [Abstract] [Full Text] [Related]

  • 25. [Effect of UFT and CBDCA combined therapy on human laryngeal cancer transplanted into nude mice].
    Kubota T, Nishimura T.
    Gan To Kagaku Ryoho; 1993 Oct 15; 20(13):1961-5. PubMed ID: 8215469
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG, Langer CJ.
    Expert Rev Anticancer Ther; 2007 Mar 15; 7(3):331-50. PubMed ID: 17338653
    [Abstract] [Full Text] [Related]

  • 29. [Effectiveness of concomitant therapy with S-1, nedaplatin, and radiation for laryngeal cancer].
    Shimane T, Mori T, Ono T, Kaburagi A, Monden T, Furuya A, Kamakazu K, Kobayashi S, Sanbe T, Suzaki H.
    Gan To Kagaku Ryoho; 2010 Feb 15; 37(2):241-4. PubMed ID: 20154477
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie's patients and patient's follow up with laryngeal preservation].
    Bessède JP, Vinh D, Genet D, Khalifa N, Aubry K, Rhein B, Orsel S, Tubiana-Mathieu N, Clavère P.
    Rev Laryngol Otol Rhinol (Bord); 2004 Feb 15; 125(2):81-8. PubMed ID: 15462166
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Concurrent chemoradiation therapy with low-dose CDDP and UFT for glottic carcinomas: evaluation using the sixth edition of the UICC TNM staging system.
    Murakami R, Nishimura R, Baba Y, Yumoto E, Oya N, Yamashita Y.
    Acta Oncol; 2006 Feb 15; 45(2):162-7. PubMed ID: 16546861
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.